7 Best Pancreatic Cancer Treatment Doctors in Faridabad for 2026

Introduction

You have just seen a CT report that mentions a pancreatic mass, and every hour since has been consumed by the question of who to trust. Your instinct might be to head straight to the largest brand-name hospital in Delhi NCR. That instinct is worth pausing. Pancreatic cancer carries a notoriously narrow margin for error. Surgical resection is the only potentially curative treatment, yet the biology of the disease demands something more than a technically proficient general surgeon.

In Faridabad, the local advantage is tangible and specific: Sarvodaya Cancer Institute runs an integrated, tumor-board-driven model that collides specialties into one room before a single incision is made. That structure is uncommon. A multidisciplinary tumor board can sharpen every downstream decision. MDTB discussion can reduce the time from diagnosis to treatment initiation for pancreatic cancer patients.

This article maps the specialists you need to know, starting with the critical difference between a general surgeon and a GI oncology surgeon. For a Whipple procedure, that distinction can be the difference between a clean R0 resection and residual disease. The names here are ranked by the clinical problem they solve first, not by hospital brand recognition.

Key Takeaways

These decision rules let you benchmark any pancreatic cancer specialist in Faridabad against concrete quality markers, not reputation alone.

• Tumor resectability dictates the first call: If imaging shows a resectable tumor, your first appointment needs to be with a GI surgical oncologist. If the disease is borderline or metastatic, start with a medical oncologist who directs systemic therapy.

• A tumor board is non-negotiable: Any center worth considering convenes a weekly multidisciplinary meeting where surgeons, medical oncologists, and radiologists review your case together before treatment begins.

• Fellowship training in GI or HPB surgery matters: A surgeon who completed a dedicated GI oncology or HPB fellowship, not just a general surgery residency, owns the sharpest technical toolkit for pancreatic resections.

• Annual Whipple volume drives outcomes: Centers and surgeons with high annual case volumes consistently achieve better perioperative mortality and R0 resection rates.

1. Dr Bharat Patodiya, Faridabad’s Dedicated GI/HPB Surgical Oncologist

For a pancreatic mass that staging confirms is resectable, Dr Bharat Patodiya is the sole GI and HPB surgical oncologist in Faridabad whose entire training track was built for this exact operation. His certificate of advanced studies in GI cancer and a diploma in lung cancer and gastrointestinal cancers both trace back to the University of Zurich. That hands-on European fellowship exposure to complex pancreatic resections is a line item few CVs in this city carry.

Before Zurich, Dr Patodiya completed his medical oncology training at Hinduja Hospital in Mumbai and went on to start his own chain of cancer care centers under Pi Cancer Care. His current practice at Sarvodaya Cancer Institute anchors a tumor board where he reviews each pancreatic case alongside medical and radiation oncologists before the surgical plan is finalized. That rhythm, where a dedicated GI surgeon who also understands systemic therapy maps the anatomy, decides the difference between a clean R0 resection and residual disease. As a second-opinion resource within Faridabad, he also coordinates access to multidisciplinary protocol reviews that catch gaps other centers might miss.

2. Dr Brahamjit Singh, Medical Oncology Director for Systemic Therapy Protocols

Director of Medical Oncology at Sarvodaya, Dr Brahamjit Singh is the entry point for pancreatic cancer that cannot go straight to surgery. Here is why his role reshapes the treatment timeline.

• Systemic therapy architect for borderline and metastatic disease: When a pancreatic tumor encases a major vessel or has already spread, surgical resection is off the table. Dr Singh designs the chemotherapy backbone around advanced regimens like FOLFIRINOX or gemcitabine-based combinations, plus targeted therapies for select molecular profiles, aiming to control disease progression and extend survival in eligible patients.

• Tumor board co-chair with surgical oncology: His protocol runs inside Sarvodaya's tumor board environment, meaning every systemic therapy decision is cross-examined by the surgical team that could later convert a borderline case into a resectable one.

• First stop for patients who present with weight loss and jaundice: Symptoms like persistent upper abdominal pain radiating to the back demand early evaluation. Dr Singh's clinic sequences diagnostic confirmation with immediate staging and chemotherapy planning, cutting the lag that this aggressive cancer exploits.

3. Dr Dinesh Pendharkar, Senior Governance and Multidisciplinary Oversight

More than 41 years in oncology governance gives Dr Dinesh Pendharkar the vantage point to spot protocol drift before it reaches the patient. At Sarvodaya Cancer Institute, he holds the senior multidisciplinary lead role that enforces what the tumor board decides. Many hospitals have an advisory board where individual practitioners keep final autonomy. Here, a consensus reached after radiology, pathology, and surgical review becomes the treatment path.

Pancreatic cancer splinters care faster than almost any other diagnosis. A medical oncologist comfortable with gemcitabine alone might delay a FOLFIRINOX switch. A general surgeon who does two Whipples a year might attempt a margin the anatomy will not support. In aggressive disease, the difference between a clean R0 resection and residual disease can turn on that exact decision. Dr Pendharkar's oversight architecture, built over four decades of clinical decision-making, catches those failure modes before they compound.

When you sit in his consultation, you are getting a verdict that survived cross-examination by the entire organ-specific team. For a disease where pancreatic cancer often develops quietly, with few symptoms until it is advanced, that institutional governance is the backstop your treatment plan needs.

4. Dr Sajjan Rajpurohit, Medical Oncology and Precision Medicine Lead (Max Hospital, Delhi NCR)

When genomic profiling must drive therapy selection in pancreatic cancer, Sarvodaya delivers molecularly informed plans inside Faridabad. The nearest precision medicine subspecialist in the NCR sits at Max Hospital. The table below maps the structural difference between approaching pancreatic cancer through an integrated local tumor board and a precision oncology referral.

5. Dr Vinod Raina, Medical Oncology and Hematology Pioneer (Fortis Memorial, Gurgaon)

When pancreatic cancer stops responding to first-line FOLFIRINOX, the algorithm resets, and the oncologist you reach for changes. Dr Vinod Raina at Fortis Memorial in Gurgaon is part of a small cohort of Indian medical oncologists whose entire careers shaped the protocols that younger specialists now follow. His hematology foundation adds a layer of marrow-rescue experience that matters when cytotoxic intensity becomes the only lever left to pull.

The practical reason to seek his consult is that he has cycled thousands of patients through regimens that are now exhausted in your case. He knows which salvage sequences carry a real chance of response and which only preserve performance status on paper.

His base at Fortis Memorial positions him as a tertiary deep-expertise resource for patients across the NCR whose chemotherapy options have plateaued. Get your current scans and treatment summary to his clinic when you are staring at a rising CA 19-9 on your third line of therapy. That is when decades of pattern recognition matter more than any single drug approval.

This is a consult reserved for the moment when standard guidelines run out of numbered options.

6. Dr Adarsh Chaudhary, GI Surgery and Pancreatic Resection Authority (Medanta, Gurgaon)

Dr Adarsh Chaudhary at Medanta operates at the ultra-high-volume end of the Whipple spectrum, the kind of personal case series where perioperative mortality curves have flattened from repetition. Studies consistently link annual pancreatic resection volume to outcomes: surgeons who perform a large number of Whipple procedures each year achieve both lower mortality and higher rates of margin-negative resections. When your pre-operative imaging shows tumor abutment of the superior mesenteric vein or portal vein requiring complex vascular reconstruction, that volume differential becomes the primary variable in whether you wake up with a clean R0 resection.

The referral calculus turns on a single question. If your pancreatic anatomy is straightforward and your mass is confined to the head without vascular involvement, Faridabad's GI surgical capability at Sarvodaya keeps you in a single integrated tumor board ecosystem. If your scan demands venous resection and reconstruction of a caliber that only a surgeon who has done hundreds of them can execute, Dr Chaudhary's series is the relevant benchmark.

7. Dr Ashok Vaid, Medical Oncology and Bone Marrow Transplant Leader (Medanta, Gurgaon)

Dr Ashok Vaid chairs medical oncology at Medanta with a portfolio that includes protocol design and clinical trial access. For pancreatic cancer patients with rare histologies such as acinar cell carcinoma or adenosquamous variants, and for those who have progressed on every standard chemotherapy option, trial enrollment becomes the treatment strategy itself. His departmental infrastructure can open genomically matched studies that are not available in community oncology settings.

Trial access matters because pancreatic cancer’s standard armamentarium is narrow. Once FOLFIRINOX and gemcitabine-based regimens are exhausted, options thin out fast.

His bone marrow transplant background connects to pancreatic cancer through the immunotherapy and cell-therapy trials now enrolling for solid tumors. The checkpoint inhibitor and cellular therapy protocols emerging for MSI-H pancreatic tumors need the kind of toxicity management infrastructure that transplant centers already operate. Dr Vaid’s chair-level role also means his team designs pathways that can incorporate basket trials for rare mutations like NTRK fusions or BRAF V600E, mutations that occasionally surface in pancreatic cancer and for which tumor-agnostic approvals already exist.

Conclusion

Your CT scan dictates who you call first. A resectable tumor sends you straight to a GI surgical oncologist inside a tumor board ecosystem. Sarvodaya Cancer Institute is the single-site option in Faridabad that delivers that surgery-first model without fragmenting care across the NCR.

Borderline or metastatic disease starts with a medical oncologist like Dr Brahamjit Singh, who can deploy systemic therapy inside the same board that will re-evaluate surgical candidacy later. The difference between a clean R0 resection and residual disease turns on whether the right specialist takes the first look at your films.

For the moments when genomic complexity, vascular anatomy, or clinical trial access demands a subspecialized escalation, the Medanta and Max specialists profiled here provide targeted routes that complement the Faridabad core.

Choose by resectability stage. The right specialist is the one who solves the problem your scan actually shows.

Frequently Asked Questions

Who are the most experienced pancreatic cancer treatment doctors in Faridabad, and what are their qualifications?

The core team operates at Sarvodaya Cancer Institute. Dr Bharat Patodiya is a GI/HPB surgical oncologist with advanced training from the University of Zurich and Hinduja Hospital. Dr Brahamjit Singh directs medical oncology and systemic therapy protocols. Dr Dinesh Pendharkar provides senior multidisciplinary governance with over 41 years of oncology experience.

How does Sarvodaya Cancer Institute's approach to pancreatic cancer treatment compare with other oncology centers in Faridabad?

Sarvodaya uses an integrated, tumor-board-driven model where surgeons, medical oncologists, radiologists, and GI pathologists review cases together before treatment begins. This single-site coordination contrasts with fragmented multi-city networks and can reduce the time from diagnosis to treatment initiation.

What diagnostic and treatment technologies are available for pancreatic cancer at Sarvodaya Cancer Institute in Faridabad?

Sarvodaya offers a thorough suite of pancreatic cancer services:

• Contrast-enhanced CT for staging

• Endoscopic ultrasound (EUS) with fine-needle aspiration for tissue diagnosis

• IMRT and IGRT precision radiotherapy

• ERCP with biliary stenting

• Molecular profiling for targeted therapies

• Minimally invasive and robotic surgical techniques for appropriate resectable cases

What should patients look for when choosing a pancreatic cancer specialist in India, and how can they verify credentials?

When selecting a specialist for pancreatic cancer, consider these qualification and process checks:

• Verify GI-specific fellowship training rather than a general surgery residency alone.

• Confirm the surgeon's annual Whipple procedure volume, high-volume centers produce measurably better perioperative outcomes.

• Check that the specialist participates in a weekly hospital tumor board.

• Request documentation of board certifications and any international fellowship training directly from the hospital.

How can patients in Faridabad access online medical oncology consultations for pancreatic cancer, and what do they cost?

Several oncologists in the Faridabad and Delhi NCR network offer online consultation platforms. Some practices list online medicine specialist consultations starting around ₹1,000 to ₹1,500 per session. Contact the specific hospital or clinic for current teleconsultation availability and fees, as pricing and schedule slots vary by doctor.

What support services, such as tumor boards, nursing, and palliative care, are offered by modern cancer care centers for pancreatic cancer patients?

Leading centers offer a range of supportive services alongside treatment:

• Weekly multidisciplinary tumor boards where all specialists review cases together.

• 24/7 nursing support for chemotherapy cycles.

• Dedicated palliative care teams for symptom management.

• Nutritional counseling specific to pancreatic insufficiency.

• Biliary stenting services for obstructive jaundice.

Sources

1. Best Pancreatic Cancer Treatment in Faridabad, Delhi NCR - www.sarvodayahospital.com

2. Best Oncologist in Faridabad | Dr. Novak Gupta - drnovakgupta.com

3. The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center. - pubmed.ncbi.nlm.nih.gov

4. [PDF] Prepared as an outcome of iCMR subcommittee on Pancreatic Cancer - www.icmr.gov.in